Markus Aly

Articles

Article: ACTA ANAESTHESIOLOGICA SCANDINAVICA. 2024;68(8):1006-1015
Postoperative pain, recovery and discharge after robot-assisted laparoscopic prostatectomy: A multicentre, single blinded, randomised controlled trial
Hallengren S; Schening A; Lindstrom A-C; Radros J; Eriksson J; Blomqvist E; Knutas R; Fallman N; Aly M; Gupta A
Article: BJUI COMPASS. 2024;5(9):999-1006
Long-term oncological outcomes after multimodal treatment for locally advanced prostate cancer
Roldan FL; Falagario UG; Olsson M; Salas RS; Aly M; Egevad L; Lantz A; Gronberg H; Akre O; Hosseini A; Wiklund NP
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2024;116(9):1459-1465
Prostate cancer incidence and mortality in men exposed to α1-adrenergic receptor antagonists
Bjornebo L; Razdan S; Discacciati A; Palsdottir T; Aly M; Nordstrom T; Eklund M; Lundon D; Gronberg H; Tewari A; Wiklund P; Kyprianou N; Lantz A
Article: EUROPEAN UROLOGY ONCOLOGY. 2024;7(4):888-896
Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years Report from the EAU Robotic Urology Section Scientific Working Group '
Pellegrino F; Falagario UG; Knipper S; Martini A; Akre O; Egevad L; Aly M; Moschovas MC; Bravi CA; Tran J; Heiniger Y; von Kempis A; Schaffar R; Carrieri G; Briganti A; Montorsi F; Rochat C-H; Mottrie A; Ahlering TE; John H; Patel V; Graefen M; Wiklund P
Article: BMC CANCER. 2024;24(1):891
Effects of an exercise intervention in primary care after robot-assisted radical cystectomy for urinary bladder cancer: a randomised controlled trial
Porserud A; Karlsson P; Aly M; Rydwik E; Torikka S; Henningsohn L; Nygren-Bonnier M; Hagstromer M
Journal article: INVESTIGATIVE UROLOGY. 2024;211(5S):e969
PD45-06 ACCURACY OF THE MRI 5-POINT LIKERT SCORE TO PREDICT EXTRA-PROSTATIC EXTENSION AND SEMINAL VESICLE INVASION IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR PROSTATE CANCER AND DEVELOPMENT OF a NEW MRI-BASED NOMOGRAM
Pellegrino F; Falagario UG; Proietti F; Brasetti A; Hagman A; Briganti A; Montorsi F; Carrieri G; Lantz A; Akre O; Aly M; Egevad L; Jaderling F; Wiklund P
Journal article: INVESTIGATIVE UROLOGY. 2024;211(5S):e219
MP14-02 IDENTIFY THE OPTIMAL CANDIDATES FOR ADJUVANT ANDROGEN DEPRIVATION THERAPY AMONG PATIENTS WITH DETECTABLE PSA AFTER RADICAL PROSTATECTOMY
Pellegrino F; Falagario UG; Knipper S; Martini A; Akre O; Aly M; Moschovas MC; Bravi CA; Tran J; Heiniger Y; von Kempis A; Schaffar R; Carrieri G; Briganti A; Montorsi F; Rochat C-H; Mottrie A; Ahlering TE; John H; Patel V; Graefen M; Wiklund P
Journal article: INVESTIGATIVE UROLOGY. 2024;211(5S):e1213
PD57-12 PSA RESPONSE AFTER RADIOTHERAPY. IS THERE A DEFINITION OF PSA PERSISTENCE AFTER RT?
Falagario UG; Pellegrino F; Abbadi A; Björnebo L; Valdman A; Carrieri GG; Briganti A; Montorsi F; Akre O; Aly M; Eklund M; Nordström T; Grönberg H; Wiklund P; Lantz A
Journal article: INVESTIGATIVE UROLOGY. 2024;211(5S):e623
PD29-12 THE IMPACT OF THE TIME ELAPSED BETWEEN PRIMARY TREATMENT AND BCR ON CANCER SPECIFIC MORTALITY IN PATIENTS WHO EXPERIENCED BCR AFTER PRIMARY TREATMENT
Pellegrino F; Falagario UG; Abbadi A; Björnebo L; Valdman A; Carrieri G; Briganti A; Montorsi F; Akre O; Aly M; Eklund M; Nordström T; Grönberg H; Lantz A; Wiklund P
Journal article: EUROPEAN UROLOGY. 2024;85:s1404-s1405
Identify the optimal candidates for adjuvant androgen deprivation therapy among patients with detectable PSA after radical prostatectomy
Pellegrino F; Falagario UG; Knipper S; Martini A; Akre O; Aly M; Moschovas MC; Bravi CA; Tran J; Heiniger Y; Von Kempis A; Schaffar R; Carrieri G; Briganti A; Montorsi F; Rochat C-H; Mottrie A; Ahlering TE; John H; Patel V; Graefen M; Wiklund P
Journal article: EUROPEAN UROLOGY. 2024;85:s1401
Time to death and clinical characteristics of patients who died for prostate cancer after robot-assisted radical prostatectomy: 20 years' report from the EAU Robotic Urology Section (ERUS) scientific working group
Falagario UG; Pellegrino F; Moschovas MC; Knipper S; Martini A; Akre O; Egevad L; Aly M; Bravi CA; Tran J; Heiniger Y; Von Kempis A; Schaffar R; Carrieri G; Briganti A; Montorsi F; Rochat C-H; Mottrie A; Ahlering TE; John H; Patel V; Graefen M; Wiklund P
Journal article: EUROPEAN UROLOGY. 2024;85:s334-s335
The risk of venous thromboembolic events in men operated with laparoscopic or open radical prostatectomy - a nationwide population-based cohort study
Bjorklund J; Rautiola J; Zelic R; Vincent PH; Wiklund P; Aly M; Akre O
Article: ANNALS OF SURGICAL ONCOLOGY. 2024;31(2):1739-1748
Risk of Postoperative Ischemic Stroke and Myocardial Infarction in Patients Operated for Cancer
Rautiola J; Bjoerklund J; Zelic R; Edgren G; Bottai M; Nilsson M; Vincent PH; Fredholm H; Falconer H; Sjovall A; Nilsson PJ; Wiklund P; Aly M; Akre O
Article: ANNALS OF SURGICAL ONCOLOGY. 2024;31(3):1789-1790
ASO Author Reflections: Arterial Ischemic Events Following Cancer Surgery: Where Do We Stand?
Rautiola J; Bjoerklund J; Zelic R; Edgren G; Bottai M; Nilsson M; Vincent PH; Fredholm H; Falconer H; Sjovall A; Nilsson PJ; Wiklund P; Aly M; Akre O
Journal article: EUROPEAN UROLOGY. 2024;85:s1402-s1403
PSA response after radiotherapy. Is there a definition of PSA persistence after RT?
Falagario UG; Pellegrino F; Abbadi A; Bjornebo L; Valdman A; Carrieri G; Briganti A; Montorsi F; Akre O; Aly M; Eklund M; Nordstrom T; Gronberg H; Wiklund P; Lantz A
Journal article: EUROPEAN UROLOGY. 2024;85:s459-s460
Accuracy of the MRI 5-point Likert score to predict extra-prostatic extension and seminal vesicle invasion in patients undergoing radical prostatectomy for prostate cancer and development of a new MRI-based nomogram.
Pellegrino F; Falagario UG; Proietti F; Brasetti A; Hagman A; Briganti A; Montorsi F; Carrieri G; Lantz A; Akre O; Aly M; Egevad L; Jaderling F; Wiklund P
Journal article: EUROPEAN UROLOGY. 2024;85:s1534-s1535
The impact of the time elapsed between primary treatment and BCR on cancer specific mortality in patients who experienced BCR after primary treatment
Pellegrino F; Falagario UG; Abbadi A; Bjornebo L; Valdman A; Carrieri G; Briganti A; Montorsi F; Akre O; Aly M; Eklund M; Nordstrom T; Gronberg H; Lantz A; Wiklund P
Article: JAMA NETWORK OPEN. 2024;7(2):e2354352
Risk of Venous Thromboembolic Events After Surgery for Cancer
Bjorklund J; Rautiola J; Zelic R; Edgren G; Bottai M; Nilsson M; Vincent PH; Fredholm H; Falconer H; Sjoevall A; Nilsson PJ; Wiklund P; Aly M; Akre O
Article: PILOT AND FEASIBILITY STUDIES. 2024;10(1):12
The feasibility of an exercise intervention after robotic-assisted radical cystectomy for urinary bladder cancer, prior to the CanMoRe trial
Porserud A; Karlsson P; Nygren-Bonnier M; Aly M; Hagstromer M
Article: NATURE GENETICS. 2023;55(12):2065-2074
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants
Wang A; Shen J; Rodriguez AA; Saunders EJ; Chen F; Janivara R; Darst BF; Sheng X; Xu Y; Chou AJ; Benlloch S; Dadaev T; Brook MN; Plym A; Sahimi A; Hoffman TJ; Takahashi A; Matsuda K; Momozawa Y; Fujita M; Laisk T; Figueredo J; Muir K; Ito S; Liu X; Uchio Y; Kubo M; Kamatani Y; Lophatananon A; Wan P; Andrews C; Lori A; Choudhury PP; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Giles GG; Southey MC; MacInnis RJ; Cybulski C; Wokolorczyk D; Lubinski J; Rentsch CT; Cho K; Mcmahon BH; Neal DE; Donovan JL; Hamdy FC; Martin RM; Nordestgaard BG; Nielsen SF; Weischer M; Bojesen SE; Roder A; Stroomberg HV; Batra J; Chambers S; Horvath L; Clements JA; Tilly W; Risbridger GP; Gronberg H; Aly M; Szulkin R; Eklund M; Nordstrom T; Pashayan N; Dunning AM; Ghoussaini M; Travis RC; Key TJ; Riboli E; Park JY; Sellers TA; Lin H-Y; Albanes D; Weinstein S; Cook MB; Mucci LA; Giovannucci E; Lindstrom S; Kraft P; Hunter DJ; Penney KL; Turman C; Tangen CM; Goodman PJ; Thompson IMJ; Hamilton RJ; Fleshner NE; Finelli A; Parent M-E; Stanford JL; Ostrander EA; Koutros S; Freeman LEB; Stampfer M; Wolk A; Hakansson N; Andriole GL; Hoover RN; Machiela MJ; Sorensen KD; Borre M; Blot WJ; Zheng W; Yeboah ED; Mensah JE; Lu Y-J; Zhang H-W; Feng N; Mao X; Wu Y; Zhao S-C; Sun Z; Thibodeau SN; McDonnell SK; Schaid DJ; West CML; Barnett G; Maier C; Schnoeller T; Luedeke M; Kibel AS; Drake BF; Cussenot O; Cancel-Tassin G; Menegaux F; Truong T; Koudou YA; John EM; Grindedal EM; Maehle L; Khaw K-T; Ingles SA; Stern MC; Vega A; Gomez-Caamano A; Fachal L; Rosenstein BS; Kerns SL; Ostrer H; Teixeira MR; Paulo P; Brandao A; Watya S; Lubwama A; Bensen JT; Butler EN; Mohler JL; Taylor JA; Kogevinas M; Dierssen-Sotos T; Castano-Vinyals G; Cannon-Albright L; Teerlink CC; Huff CD; Pilie P; Yu Y; Bohlender RJ; Gu J; Strom SS; Multigner L; Blanchet P; Brureau L; Kaneva R; Slavov C; Mitev V; Leach RJ; Brenner H; Chen X; Holleczek B; Schoettker B; Klein EA; Hsing AW; Kittles RA; Murphy AB; Logothetis CJ; Kim J; Neuhausen SL; Steele L; Ding YC; Isaacs WB; Nemesure B; Hennis AJM; Carpten J; Pandha H; Michael A; De Ruyck K; De Meerleer G; Ost P; Xu J; Razack A; Lim J; Teo S-H; Newcomb LF; Lin DW; Fowke JH; Neslund-Dudas CM; Rybicki BA; Gamulin M; Lessel D; Kulis T; Usmani N; Abraham A; Singhal S; Parliament M; Claessens F; Joniau S; Van den Broeck T; Gago-Dominguez M; Castelao JE; Martinez ME; Larkin S; Townsend PA; Aukim-Hastie C; Bush WS; Aldrich MC; Crawford DC; Srivastava S; Cullen J; Petrovics G; Casey G; Wang Y; Tettey Y; Lachance J; Tang W; Biritwum RB; Adjei AA; Tay E; Truelove A; Niwa S; Yamoah K; Govindasami K; Chokkalingam AP; Keaton JM; Hellwege JN; Clark PE; Jalloh M; Gueye SM; Niang L; Ogunbiyi O; Shittu O; Amodu O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Diop H; Gundell SM; Roobol MJ; Jenster G; van Schaik RHN; Hu JJ; Sanderson M; Kachuri L; Varma R; McKean-Cowdin R; Torres M; Preuss MH; Loos RJF; Zawistowski M; Zollner S; Lu Z; Van Den Eeden SK; Easton DF; Ambs S; Edwards TL; Magi R; Rebbeck TR; Fritsche L; Chanock SJ; Berndt SI; Wiklund F; Nakagawa H; Witte JS; Gaziano JM; Justice AC; Mancuso N; Terao C; Eeles RA; Kote-Jarai Z; Madduri RK; Conti DV; Haiman CAAll authors
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2023;57:s104-s105
P069 PSA persistence after prostatectomy – prognosis and the effect of adjuvant radiotherapy
Möller A; Nordström T; Eklund M; Akre O; Egevad L; Aly M
Journal article: ANNALS OF ONCOLOGY. 2023;34:s1217
Correlation between overall survival and bladder-intact event-free survival in cystectomy-ineligible/refusal muscleinvasive bladder cancer patients in Sweden
Kwok KH; Laurin O; Baculea S; Cote S; Spigelman S; Szulkin R; Schain F; Jones CV; Aly M
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2023;55:s84
PE041 The impact of lymph-node dissection during radical prostatectomy on the risk of venous thromboembolic complications – a population-based study
Rautiola J; Björklund J; Zelic R; Vincent PH; Wiklund P; Aly M; Akre O
Article: EJSO. 2023;49(9):106943
Association between early mobilisation after abdominal cancer surgery and postoperative complications
Porserud A; Aly M; Nygren-Bonnier M; Hagstromer M
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2023;51:89-94
Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate Cancer
Lantz A; Nordlund P; Falagario U; Joderling F; Ozbek O; Clements M; Discacciati A; Gronberg H; Eklund M; Stricker P; Emberton M; Aly M; Nordstrom T
Journal article: INVESTIGATIVE UROLOGY. 2023;209(Supplement 4):e997
PD38-11 THE STOCKHOLM3 PROSTATE CANCER SCREENING TRIAL (STHLM3): AN INTERIM ANALYSIS OF MORTALITY RESULTS AFTER 6.5 YEARS OF FOLLOW-UP
Micoli C; Crippa A; Discacciati A; Palsdottir T; Vigneswaran H; Aly M; Adolfsson J; Lindberg J; Wiklund P; Thompson J; Brandberg Y; Clements M; Egevad L; Grönberg H; Nordström T; Eklund M
Journal article: INVESTIGATIVE UROLOGY. 2023;209(Supplement 4):e419
PD15-04 PREDICTION OF PROSTATE CANCER SPECIFIC MORTALITY IN MEN UNDERGOING RADIOTHERAPY WITH OR WITHOUT HORMONAL TREATMENT, RISK STRATIFICATION BASED ON CLINICAL CHARACTERISTICS AND PSA TREATMENT RESPONSE
Falagario U; Bogdanovic D; Björnebo L; Abbadi A; Valdman A; Eklund M; Nordström T; Aly M; Grönberg H; Wiklund P; Lantz A
Journal article: INVESTIGATIVE UROLOGY. 2023;209(Supplement 4):e214
MP17-06 VALIDATION OF EAU RISK GROUPS FOR BIOCHEMICAL RECURRENCE AFTER RADIOTHERAPY AND RADICAL PROSTATECTOMY FOR PREDICTION OF PROSTATE CANCER MORTALITY
Falagario U; Bogdanovic D; Björnebo L; Abbadi A; Valdman A; Eklund M; Nordström T; Aly M; Grönberg H; Lantz A; Wiklund P
Journal article: EUROPEAN UROLOGY. 2023;83:s1266-s1267
The Stockholm3 prostate cancer screening trial (STHLM3): An interim analysis of mortality results after 6.5 years of follow-up
Micoli C; Crippa A; Discacciati A; Vigneswaran H; Palsdottir T; Clements M; Aly M; Adolfsson J; Fredrik W; Wiklund P; James T; Lindberg J; Gronberg H; Egevad L; Nordstrom T; Eklund M
Journal article: EUROPEAN UROLOGY. 2023;83:s371
A0261 The risk of ischemic stroke and myocardial infarction in prostate cancer patients treated with radical prostatectomy – population-based nationwide matched cohort study
Rautiola J; Björklund J; Zelic R; Vincent PH; Wiklund P; Aly M; Akre O
Journal article: EUROPEAN UROLOGY. 2023;83:s369-s370
A0260 The risk of venous thromboembolic events among men operated with radical prostatectomy - A nationwide population-based cohort study
Björklund J; Rautiola J; Zelic R; Vincent PH; Wiklund P; Aly M; Akre O
Journal article: EUROPEAN UROLOGY. 2023;83:s209-s210
A0152 The risk of Venous thromboembolic events in patients operated with radical cystectomy - a nationwide population-based cohort study
Björklund J; Rautiola J; Zelic R; Vincent PH; Wiklund P; Aly M; Akre O
Journal article: EUROPEAN UROLOGY. 2023;83:s208
A0151 The risk of arterial thromboembolic complications in bladder cancer patients after radical cystectomy – population-based nationwide matched cohort study
Rautiola J; Björklund J; Zelic R; Vincent PH; Wiklund P; Aly M; Akre O
Journal article: EUROPEAN UROLOGY. 2023;83:s1613-s1614
Prediction of prostate cancer specific mortality in men undergoing radiotherapy with or without hormonal treatment, risk stratification based on clinical characteristics and PSA treatment response
Falagario UG; Bogdanovic D; Bjornebo L; Abbadi A; Valdman A; Eklund M; Nordstrom T; Aly M; Gronberg H; Wiklund P; Lantz A
Journal article: EUROPEAN UROLOGY. 2023;83:s379-s380
A0266 Validation of EAU Risk groups for biochemical recurrence after radiotherapy and radical prostatectomy for prediction of prostate cancer mortality
Falagario UG; Bogdanovic D; Björnebo L; Abbadi A; Valdman A; Eklund M; Nordström T; Aly M; Grönberg H; Lantz A; Wiklund P
Article: ACTA ONCOLOGICA. 2022;61(11):1377-1385
Cardiovascular, bone, and metabolic health in men with castrate-resistant prostate cancer treated with androgen deprivation: a matched cohort study
Khoshkar Y; Vigneswaran HTT; Eloranta S; Andersson TM-L; Schain F; Boman A; Dahlkild M; Liwing J; Leval A; Akre O; Aly M
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2022;44:46-51
Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data
Ventimiglia E; Bill-Axelson A; Adolfsson J; Aly M; Eklund M; Westerberg M; Stattin P; Garmo H
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2022;44:69-75
Digital Rectal Examination in Stockholm3 Biomarker-based Prostate Cancer Screening
Andersson J; Palsdottir T; Lantz A; Aly M; Gronberg H; Egevad L; Eklund M; Nordstrom T
Article: JAMA ONCOLOGY. 2022;8(7):1019-1026
Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality
Bjornebo L; Nordstrom T; Discacciati A; Palsdottir T; Aly M; Gronberg H; Eklund M; Lantz A
Article: VACCINE. 2022;40(27):3797-3801
Travel vaccines are strongly associated to reduced mortality in prostate cancer patients-a real effect or residual confounding?
Moeller A; Schwamborn K; Spillmann A; Hoogstraate J; Szulkin R; Akre O; Egevad L; Clements M; Aly M
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2022;56(3):169-175
Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists
Bonde TM; Westerberg M; Aly M; Eklund M; Adolfsson J; Bill-Axelson A; Garmo H; Stattin P; Robinson D
Journal article: INVESTIGATIVE UROLOGY. 2022;207(Supplement 5):e255
PD13-11 DISEASE TRAJECTORIES AND OUTCOMES FOR MEN WITH CASTRATION RESISTANT PROSTATE CANCER BY USE OF NATION-WIDE POPULATION-BASED OBSERVATIONAL DATA
Ventimiglia E; Bill-Axelson A; Aly M; Eklund M; Stattin P; Garmo H
Journal article: INVESTIGATIVE UROLOGY. 2022;207(Supplement 5):e41
PD03-02 LONG-TERM EFFECTS OF 5Α-REDUCTASE INHIBITORS ON PROSTATE CANCER MORTALITY - A LARGE POPULATION-BASED PROSPECTIVE STUDY
Björnebo L; Nordström T; Discacciati A; Palsdottir T; Aly M; Grönberg H; Eklund M; Lantz A
Article: BJUI COMPASS. 2022;3(2):173-183
Mortality in men with castration-resistant prostate cancer-A long-term follow-up of a population-based real-world cohort
Khoshkar Y; Westerberg M; Adolfsson J; Bill-Axelson A; Olsson H; Eklund M; Akre O; Garmo H; Aly M
Article: BJU INTERNATIONAL. 2022;129(3):318-324
The 90-day cause-specific mortality after radical prostatectomy: a nationwide population-based study
Bjorklund J; Stattin P; Ronmark E; Aly M; Akre O
Journal article: EUROPEAN UROLOGY. 2022;81:s792-s793
A0527 Disease trajectories and outcomes for men with castration resistant prostate cancer by use of nation-wide population-based observational data
Ventimiglia E; Bill-Axelson A; Aly M; Eklund M; Stattin P; Garmo H
Journal article: EUROPEAN UROLOGY. 2022;81:s561-s562
A0362 Long-term effects of 5α-reductase inhibitors on prostate cancer mortality: A large population-based prospective study
Björnebo L; Nordström T; Discacciati A; Palsdottir T; Aly M; Grönberg H; Eklund M; Lantz A
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2021;385(10):908-920
MRI-Targeted or Standard Biopsy in Prostate Cancer Screening
Eklund M; Jaderling F; Discacciati A; Bergman M; Annerstedt M; Aly M; Glaessgen A; Carlsson S; Groenberg H; Nordstroem T
Article: LANCET ONCOLOGY. 2021;22(9):1240-1249
Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial
Nordstrom T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jaderling F; Eklund M; Gronberg H
Article: EUROPEAN UROLOGY ONCOLOGY. 2021;4(4):570-579
Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study
Karlsson Q; Brook MN; Dadaev T; Wakerell S; Saunders EJ; Muir K; Neal DE; Giles GG; MacInnis RJ; Thibodeau SN; McDonnell SK; Cannon-Albright L; Teixeira MR; Paulo P; Cardoso M; Huff C; Li D; Yao Y; Scheet P; Permuth JB; Stanford JL; Dai JY; Ostrander EA; Cussenot O; Cancel-Tassin G; Hoegel J; Herkommer K; Schleutker J; Tammela TLJ; Rathinakannan V; Sipeky C; Wiklund F; Gronberg H; Aly M; Isaacs WB; Dickinson JL; FitzGerald LM; Chua MLK; Nguyen-Dumont T; Consortium P; Schaid DJ; Southey MC; Eeles RA; Kote-Jarai Z
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2021;55(4):299-306
Real world treatment utilization patterns in patients with castration-resistant prostate cancer
Vigneswaran HT; Warnqvist A; Andersson TML; Leval A; Eklund M; Nordstrom T; Eloranta S; Schain F; Dearden L; Liwing J; Mehra M; Nair S; Pettersson A; Akre O; Aly M
Journal article: EUROPEAN UROLOGY. 2021;79:s1429
P1014 Prostate cancer screening using prostate-specific antigen, a multiplex blood-test, magnetic resonance imaging and targeted prostate biopsies: The STHLM3MRI trial
Nordström T; Discacciati A; Bergman M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H
Journal article: EUROPEAN UROLOGY. 2021;79:s1430
P1015 MRI-targeted or systematic biopsies in prostate cancer screening: The STHLM3MRI trial
Eklund M; Jäderling F; Discacciati A; Bergman M; Annerstedt M; Aly M; Glaessgen A; Carlsson S; Grönberg H; Nordström T
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2021;24:11-16
Identifying Prostate Cancer Among Men with Lower Urinary Tract Symptoms
Nordstrom T; Engel JC; Bergman M; Egevad L; Aly M; Eklund M; Palsdottir T; Gronberg H
Article: JOURNAL OF ROBOTIC SURGERY. 2021;15(1):105-114
Oncologic outcomes of patients with incidental prostate cancer who underwent RARC: a comparison between nerve sparing and non-nerve sparing approach
Chessa F; Moller A; Collins J; Laurin O; Aly M; Schiavina R; Adding C; Distefano C; Akre O; Bertaccini A; Hosseini A; Brunocilla E; Wiklund P
Article: NATURE GENETICS. 2021;53(1):65-75
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
Conti DV; Darst BF; Moss LC; Saunders EJ; Sheng X; Chou A; Schumacher FR; Al Olama AA; Benlloch S; Dadaev T; Brook MN; Sahimi A; Hoffmann TJ; Takahashi A; Matsuda K; Momozawa Y; Fujita M; Muir K; Lophatananon A; Wan P; Le Marchand L; Wilkens LR; Stevens VL; Gapstur SM; Carter BD; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Giles GG; Southey MC; MacInnis RJ; Cybulski C; Wokolorczyk D; Lubinski J; Neal DE; Donovan JL; Hamdy FC; Martin RM; Nordestgaard BG; Nielsen SF; Weischer M; Bojesen SE; Roder MA; Iversen P; Batra J; Chambers S; Moya L; Horvath L; Clements JA; Tilley W; Risbridger GP; Gronberg H; Aly M; Szulkin R; Eklund M; Nordstrom T; Pashayan N; Dunning AM; Ghoussaini M; Travis RC; Key TJ; Riboli E; Park JY; Sellers TA; Lin H-Y; Albanes D; Weinstein SJ; Mucci LA; Giovannucci E; Lindstrom S; Kraft P; Hunter DJ; Penney KL; Turman C; Tangen CM; Goodman PJ; Thompson IMJ; Hamilton RJ; Fleshner NE; Finelli A; Parent M-E; Stanford JL; Ostrander EA; Geybels MS; Koutros S; Freeman LEB; Stampfer M; Wolk A; Hakansson N; Andriole GL; Hoover RN; Machiela MJ; Sorensen KD; Borre M; Blot WJ; Zheng W; Yeboah ED; Mensah JE; Lu Y-J; Zhang H-W; Feng N; Mao X; Wu Y; Zhao S-C; Sun Z; Thibodeau SN; McDonnell SK; Schaid DJ; West CML; Burnet N; Barnett G; Maier C; Schnoeller T; Luedeke M; Kibel AS; Drake BF; Cussenot O; Cancel-Tassin G; Menegaux F; Truong T; Koudou YA; John EM; Grindedal EM; Maehle L; Khaw K-T; Ingles SA; Stern MC; Vega A; Gomez-Caamano A; Fachal L; Rosenstein BS; Kerns SL; Ostrer H; Teixeira MR; Paulo P; Brandao A; Watya S; Lubwama A; Bensen JT; Fontham ETH; Mohler J; Taylor JA; Kogevinas M; Llorca J; Castano-Vinyals G; Cannon-Albright L; Teerlink CC; Huff CD; Strom SS; Multigner L; Blanchet P; Brureau L; Kaneva R; Slavov C; Mitev V; Leach RJ; Weaver B; Brenner H; Cuk K; Holleczek B; Saum K-U; Klein EA; Hsing AW; Kittles RA; Murphy AB; Logothetis CJ; Kim J; Neuhausen SL; Steele L; Ding YC; Isaacs WB; Nemesure B; Hennis AJM; Carpten J; Pandha H; Michael A; De Ruyck K; De Meerleer G; Ost P; Xu J; Razack A; Lim J; Teo S-H; Newcomb LF; Lin DW; Fowke JH; Neslund-Dudas C; Rybicki BA; Gamulin M; Lessel D; Kulis T; Usmani N; Singhal S; Parliament M; Claessens F; Joniau S; Van den Broeck T; Gago-Dominguez M; Castelao JE; Martinez ME; Larkin S; Townsend PA; Aukim-Hastie C; Bush WS; Aldrich MC; Crawford DC; Srivastava S; Cullen JC; Petrovics G; Casey G; Roobol MJ; Jenster G; van Schaik RHN; Hu JJ; Sanderson M; Varma R; McKean-Cowdin R; Torres M; Mancuso N; Berndt SI; Van den Eeden SK; Easton DF; Chanock SJ; Cook MB; Wiklund F; Nakagawa H; Witte JS; Eeles RA; Kote-Jarai Z; Haiman CA
Article: EUROPEAN JOURNAL OF HUMAN GENETICS. 2020;28(10):1467-1475
The effect of sample size on polygenic hazard models for prostate cancer
Karunamuni RA; Huynh-Le M-P; Fan CC; Eeles RA; Easton DF; Kote-Jarai Z; Al Olama AA; Garcia SB; Muir K; Gronberg H; Wiklund F; Aly M; Schleutker J; Sipeky C; Tammela TLJ; Nordestgaard BG; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw K-T; Thibodeau SN; McDonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Wokolorczyk D; Kluzniak W; Cannon-Albright L; Brenner H; Ben S; Holleczek B; Park JY; Sellers TA; Lin H-Y; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; Spurdle A; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Mills IG; Andreassen OA; Dale AM; Seibert TM
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2020;29(9):1731-1738
A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data
Huynh-Le M-P; Fan CC; Karunamuni R; Walsh EI; Turner EL; Lane JA; Martin RM; Neal DE; Donovan JL; Hamdy FC; Parsons JK; Eeles RA; Easton DF; Kote-Jarai Z; Al Olama AA; Garcia SB; Muir K; Gronberg H; Wiklund F; Aly M; Schleutker J; Sipeky C; Tammela TLJ; Nordestgaard BG; Key TJ; Travis RC; Pharoah PD; Pashayan N; Khaw K-T; Thibodeau SN; McDonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Wokolorczyk D; Kluzniak W; Cannon-Albright LA; Brenner H; Ben S; Holleczek B; Park JY; Sellers TA; Lin H-Y; Slavov CK; Kaneva RP; Mitev VI; Batra J; Clements JA; Spurdle AB; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Mills IG; Andreassen OA; Dale AM; Seibert TM
Article: BMC CANCER. 2020;20(1):805
The CanMoRe trial - evaluating the effects of an exercise intervention after robotic-assisted radical cystectomy for urinary bladder cancer: the study protocol of a randomised controlled trial
Porserud A; Karlsson P; Rydwik E; Aly M; Henningsohn L; Nygren-Bonnier M; Hagstromer M
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2020;19:e1522-e1524
1017 Oncologic outcomes of robot assisted vs. open radical cystectomy: Results from a high-volume referral center
Chessa F; Luciani L; Moller A; Laurin O; Aly M; Adding C; Schiavina R; Hosseini A; Brunocilla E; Akre O; Wiklund P
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2020;19:e182
58 Adding random systematic biopsies to MRI-fusion targeted prostate biopsy procedures: Always, in selected cases, or never?
Bergman MCA; Mortezawi A; Picker W; Aly M; Jäderling F; Haug E; Eklund M; Nordström T
Journal article: INVESTIGATIVE UROLOGY. 2020;203(Supplement 4)
MP74-06 90-DAY CAUSE-SPECIFIC MORTALITY AFTER RADICAL PROSTATECTOMY. NATIONWIDE POPULATION-BASED SWEDISH REGISTRY STUDY
Björklund* J; Stattin P; Aly M; Akre O
Journal article: INVESTIGATIVE UROLOGY. 2020;203(Supplement 4)
PD10-06 REAL-WORLD TREATMENT PATTERNS IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER
Vigneswaran* HT; Warnqvist A; Andersson TML; Leval A; Schain F; Liwing J; Eloranta S; Pettersson A; Akre O; Aly M
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2020;54(2):115-121
Survival in patients diagnosed with castration-resistant prostate cancer: a population-based observational study in Sweden
Aly M; Leval A; Schain F; Liwing J; Lawson J; Vago E; Nordstrom T; Andersson TM-L; Sjoland E; Wang C; Eloranta S; Akre O
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(6_suppl):tps378
MRI-targeted biopsies in prostate cancer screening and the value of its combination with blood-based risk-prediction: The randomized, diagnostic study STHLM3MRI.
Nordström T; Discacciati A; Jäderling F; Karlsson SG; Aly M; Gronberg H; Eklund M
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2020;54(1):1-6
Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50-69 years with PSA ≥3 ng/ml
Engel JC; Palsdottir T; Aly M; Egevad L; Gronberg H; Eklund M; Nordstrom T
Article: JAMA NETWORK OPEN. 2019;2(11):e1914689
Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results
Beckmann K; Crawley D; Nordstrom T; Aly M; Olsson H; Lantz A; Abd Jalal NB; Garmo H; Adolfsson J; Eklund M; Van Hemelrijck M
Article: EJSO. 2019;45(10):1847-1853
Objectively measured mobilisation is enhanced by a new behaviour support tool in patients undergoing abdominal cancer surgery
Porserud A; Aly M; Nygren-Bonnier M; Hagstromer M
Article: EUROPEAN UROLOGY ONCOLOGY. 2019;2(5):490-496
A Unified Prostate Cancer Risk Prediction Model Combining the Stockholm3 Test and Magnetic Resonance Imaging
Palsdottir T; Nordstrom T; Aly M; Jaderling F; Clements M; Gronberg H; Eklund M
Article: EUROPEAN UROLOGY FOCUS. 2019;5(5):842-848
Poor Follow-up After Elevated Prostate-specific Antigen Tests: A Population-based Cohort Study
Aly M; Clements M; Weibull CE; Nordstrom T; Naslund E; Adolfsson J; Gronberg H
Article: PROSTATE CANCER AND PROSTATIC DISEASES. 2019;22(3):391-398
Preoperative staging using magnetic resonance imaging and risk of positive surgical margins after prostate-cancer surgery
Jaderling F; Akre O; Aly M; Bjorklund J; Olsson M; Adding C; Oberg M; Blomqvist L; Nyberg T; Wiklund P; Carlsson S
Article: BMC UROLOGY. 2019;19(1):73
Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?
Beckmann K; Kinsella N; Olsson H; Lantz AW; Nordstrom T; Aly M; Adolfsson J; Eklund M; Van Hemelrijck M
Article: BMJ OPEN. 2019;9(6):e027816
Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI
Nordstrom T; Jaderling F; Carlsson S; Aly M; Gronberg H; Eklund M
Journal article: JOURNAL OF RADIATION ONCOLOGY. 2019;8(2):225-231
Salvage radiation therapy following radical prostatectomy in Stockholm County in 2008-2016
Falk J; Aly M; Berglund A; Nordstrom T; Valdman A
Journal article: INVESTIGATIVE UROLOGY. 2019;201(Supplement 4)
MP48-18 IS PSA ‘SCREENING’ BEHAVIOUR ASSOCIATED WITH UPTAKE OF ACTIVE SURVEILLANCE IN MEN WITH LOW RISK PROSTATE CANCER?
Beckmann* K; Kinsella N; Olsen H; Wallerstedt-Lantz A; Nordstrom T; Aly M; Adolfsson J; Eklund M; Van Hemelrijck M
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2019;18(1):e287-e289
218 Oncologic outcomes of patients with incidental prostate cancer who underwent robot-assisted radical cystectomy: A comparison between nerve sparing and non-nerve sparing approach
Chessa F; Moller A; Laurin O; Adding C; Aly M; Collins J; Luciani L; Schiavina R; Brunocilla E; Akre O; Hosseini A; Wiklund P
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2019;18(1):e1349-e1350
1006 Evaluation of enhanced mobilisation with individual goal-setting and self-monitoring after abdominal surgery due to cancer
Porserud A; Aly M; Nygren-Bonnier M; Hagströmer M
Article: PROSTATE CANCER AND PROSTATIC DISEASES. 2019;22(1):137-142
The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort
Moller A; Olsson H; Gronberg H; Eklund M; Aly M; Nordstrom T
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2019;18(1):e1532
1132 The effect of common diabetes medications on PSA levels in men without prostate cancer
Jalal NBA; Garmo H; Nordstrom T; Aly M; Eklund M; Aldofsson J; Van Hemelrijck M; Beckmann K
Article: PLOS ONE. 2019;14(6):e0218280
Are Prostate Specific-Antigen (PSA) and age associated with the risk of ISUP Grade 1 prostate cancer? Results from 72 996 individual biopsy cores in 6 083 men from the Stockholm3 study
Palsdottir T; Nordstrom T; Aly M; Lindberg J; Clements M; Egevad L; Gronberg H; Eklund M
Article: EUROPEAN UROLOGY. 2018;74(6):722-728
Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging
Gronberg H; Eklund M; Picker W; Aly M; Jaderling F; Adolfsson J; Landquist M; Haug ES; Strom P; Carlsson S; Nordstrom T
Article: GENOME MEDICINE. 2018;10(1):85
Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis
Mayrhofer M; De Laere B; Whitington T; Van Oyen P; Ghysel C; Ampe J; Ost P; Demey W; Hoekx L; Schrijvers D; Brouwers B; Lybaert W; Everaert E; De Maeseneer D; Strijbos M; Bols A; Fransis K; Oeyen S; van Dam P-J; Van den Eynden G; Rutten A; Aly M; Nordstrom T; Van Laere S; Rantalainen M; Rajan P; Egevad L; Ullen A; Yachnin J; Dirix L; Gronberg H; Lindberg J
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2018;17(14):e2898-e2899
P078 Lower Urinary Tract Symptoms (LUTS) not associated to increased risk of prostate cancer
Engel JC; Aly M; Grönberg H; Eklund M; Nordström T
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2018;17(8):225-226
P95 Oncologic outcomes of robot assisted vs open radical cystectomy: Results from a high-volume referral centre
Chessa F; Möller A; Schiavina R; Borghesi M; Laurin O; Dababneh H; Aly M; Adding C; Miyakawa A; Pultrone C; Akre O; Hosseini A; Brunocilla E; Wiklund P
Article: EUROPEAN UROLOGY FOCUS. 2018;4(5):707-710
The Stockholm-3 (STHLM3) Model can Improve Prostate Cancer Diagnostics in Men Aged 50-69 yr Compared with Current Prostate Cancer Testing
Eklund M; Nordstrom T; Aly M; Adolfsson J; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Presti JC; StLezin M; Clements M; Egevad L; Gronberg H
Article: EUROPEAN UROLOGY. 2018;74(2):204-210
The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential
Strom P; Nordstrom T; Aly M; Egevad L; Gronberg H; Eklund M
Article: NATURE GENETICS. 2018;50(7):928-936
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Schumacher FR; Al Olama AA; Berndt SI; Benlloch S; Ahmed M; Saunders EJ; Dadaev T; Leongamornlert D; Anokian E; Cieza-Borrella C; Goh C; Brook MN; Sheng X; Fachal L; Dennis J; Tyrer J; Muir K; Lophatananon A; Stevens VL; Gapstur SM; Carter BD; Tangen CM; Goodman PJ; Thompson IMJ; Batra J; Chambers S; Moya L; Clements J; Horvath L; Tilley W; Risbridger GP; Gronberg H; Aly M; Nordstrom T; Pharoah P; Pashayan N; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Albanes D; Weinstein S; Wolk A; Hakansson N; West CML; Dunning AM; Burnet N; Mucci LA; Giovannucci E; Andriole GL; Cussenot O; Cancel-Tassin G; Koutros S; Freeman LEB; Sorensen KD; Orntoft TF; Borre M; Maehle L; Grindedal EM; Neal DE; Donovan JL; Hamdy FC; Martin RM; Travis RC; Key TJ; Hamilton RJ; Fleshner NE; Finelli A; Ingles SA; Stern MC; Rosenstein BS; Kerns SL; Ostrer H; Lu Y-J; Zhang H-W; Feng N; Mao X; Guo X; Wang G; Sun Z; Giles GG; Southey MC; MacInnis RJ; FitzGerald LM; Kibel AS; Drake BF; Vega A; Gomez-Caamano A; Szulkin R; Eklund M; Kogevinas M; Llorca J; Castano-Vinyals G; Penney KL; Stampfer M; Park JY; Sellers TA; Lin H-Y; Stanford JL; Cybulski C; Wokolorczyk D; Lubinski J; Ostrander EA; Geybels MS; Nordestgaard BG; Nielsen SF; Weischer M; Bisbjerg R; Roder MA; Iversen P; Brenner H; Cuk K; Holleczek B; Maier C; Luedeke M; Schnoeller T; Kim J; Logothetis CJ; John EM; Teixeira MR; Paulo P; Cardoso M; Neuhausen SL; Steele L; Ding YC; De Ruyck K; De Meerleer G; Ost P; Razack A; Lim J; Teo S-H; Lin DW; Newcomb LF; Lessel D; Gamulin M; Kulis T; Kaneva R; Usmani N; Singhal S; Slavov C; Mitev V; Parliament M; Claessens F; Joniau S; Van den Broeck T; Larkin S; Townsend PA; Aukim-Hastie C; Dominguez MG; Castelao JE; Martinez ME; Roobol MJ; Jenster G; van Schaik RHN; Menegaux F; Truong T; Koudou YA; Xu J; Khaw K-T; Cannon-Albright L; Pandha H; Michael A; Thibodeau SN; McDonnell SK; Schaid DJ; Lindstrom S; Turman C; Ma J; Hunter DJ; Riboli E; Siddiq A; Canzian F; Kolonel LN; Le Marchand L; Hoover RN; Machiela MJ; Cui Z; Kraft P; Conti DV; Easton DF; Wiklund F; Chanock SJ; Henderson BE; Kote-Jarai Z; Haiman CA; Eeles RA
Article: NATURE COMMUNICATIONS. 2018;9(1):2256
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants
Dadaev T; Saunders EJ; Newcombe PJ; Anokian E; Leongamornlert DA; Brook MN; Cieza-Borrella C; Mijuskovic M; Wakerell S; Al Olama AA; Schumacher FR; Berndt SI; Benlloch S; Ahmed M; Goh C; Sheng X; Zhang Z; Muir K; Govindasami K; Lophatananon A; Stevens VL; Gapstur SM; Carter BD; Tangen CM; Goodman P; Thompson IMJ; Batra J; Chambers S; Moya L; Clements J; Horvath L; Tilley W; Risbridger G; Gronberg H; Aly M; Nordstrom T; Pharoah P; Pashayan N; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Albanes D; Weinstein S; Wolk A; Hakansson N; West C; Dunning AM; Burnet N; Mucci L; Giovannucci E; Andriole G; Cussenot O; Cancel-Tassin G; Koutros S; Freeman LEB; Sorensen KD; Orntoft TF; Borre M; Maehle L; Grindedal EM; Neal DE; Donovan JL; Hamdy FC; Martin RM; Travis RC; Key TJ; Hamilton RJ; Fleshner NE; Finelli A; Ingles SA; Stern MC; Rosenstein B; Kerns S; Ostrer H; Lu Y-J; Zhang H-W; Feng N; Mao X; Guo X; Wang G; Sun Z; Giles GG; Southey MC; MacInnis RJ; FitzGerald LM; Kibel AS; Drake BF; Vega A; Gomez-Caamano A; Fachal L; Szulkin R; Eklund M; Kogevinas M; Llorca J; Castano-Vinyals G; Penney KL; Stampfer M; Park JY; Sellers TA; Lin H-Y; Stanford JL; Cybulski C; Wokolorczyk D; Lubinski J; Ostrander EA; Geybels MS; Nordestgaard BG; Nielsen SF; Weisher M; Bisbjerg R; Roder MA; Iversen P; Brenner H; Cuk K; Holleczek B; Maier C; Luedeke M; Schnoeller T; Kim J; Logothetis CJ; John EM; Teixeira MR; Paulo P; Cardoso M; Neuhausen SL; Steele L; Ding YC; De Ruyck K; De Meerleer G; Ost P; Razack A; Lim J; Teo S-H; Lin DW; Newcomb LF; Lessel D; Gamulin M; Kulis T; Kaneva R; Usmani N; Slavov C; Mitev V; Parliament M; Singhal S; Claessens F; Joniau S; Van den Broeck T; Larkin S; Townsend PA; Aukim-Hastie C; Gago-Dominguez M; Castelao JE; Martinez ME; Roobol MJ; Jenster G; van Schaik RHN; Menegaux F; Truong T; Koudou YA; Xu J; Khaw K-T; Cannon-Albright L; Pandha H; Michael A; Kierzek A; Thibodeau SN; McDonnell SK; Schaid DJ; Lindstrom S; Turman C; Ma J; Hunter DJ; Riboli E; Siddiq A; Canzian F; Kolonel LN; Le Marchand L; Hoover RN; Machiela MJ; Kraft P; Freedman M; Wiklund F; Chanock S; Henderson BE; Easton DF; Haiman CA; Eeles RA; Conti DV; Kote-Jarai Z
Article: EUROPEAN UROLOGY FOCUS. 2018;4(3):385-387
Balancing Overdiagnosis and Early Detection of Prostate Cancer using the Stockholm-3 Model
Nordstrom T; Gronberg H; Adolfsson J; Egevad L; Aly M; Eklund M
Article: PROSTATE CANCER AND PROSTATIC DISEASES. 2018;21(1):57-63
Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer
Nordstrom T; Akre O; Aly M; Gronberg H; Eklund M
Article: BMJ-BRITISH MEDICAL JOURNAL. 2018;360:j5757
Polygenic hazard score to guide screening for aggressive - prostate cancer: development and validation in large scale - cohorts
Seibert TM; Fan CC; Wang Y; Zuber V; Karunamuni R; Parsons JK; Eeles RA; Easton DF; Kote-Jarai Z; Al Olama AA; Garcia SB; Muir K; Gronberg H; Wiklund F; Aly M; Schleutker J; Sipeky C; Tammela TLJ; Nordestgaard BG; Nielsen SF; Weischer M; Bisbjerg R; Roder MA; Iversen P; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw K-T; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Wokolorczyk D; Kluzniak W; Cannon-Albright L; Brenner H; Cuk K; Saum K-U; Park JY; Sellers TA; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; Spurdle A; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; Karow DS; Mills IG; Andreassen OA; Dale AM
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2017;16(10):e2628-e2629
O2 A multistep approach for detection of prostate cancer using prostate-specific antigen, the Stockholm 3 Test, and MRI-targeted Biopsies: Initial data from the STHLM3 MRI Project
Nordström; Picker W; Aly M; Jäderling F; Adolfsson J; Ström P; Haug ES; Eklund M; Carlsson S; Grönberg H
Article: BRITISH JOURNAL OF CANCER. 2017;117(5):734-743
Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium
Lophatananon A; Stewart-Brown S; Kote-Jarai Z; Al Olama AA; Garcia SB; Neal DE; Hamdy FC; Donovan JL; Giles GG; Fitzgerald LM; Southey MC; Pharoah P; Pashayan N; Gronberg H; Wiklund F; Aly M; Stanford JL; Brenner H; Dieffenbach AK; Arndt V; Park JY; Lin H-Y; Sellers T; Slavov C; Kaneva R; Mitev V; Batra J; Spurdle A; Clements JA; Easton D; Eeles RA; Muir K
Article: CANCER DISCOVERY. 2016;6(9):1052-1067
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
Kar SP; Beesley J; Al Olama AA; Michailidou K; Tyrer J; Kote-Jarai ZA; Lawrenson K; Lindstrom S; Ramus SJ; Thompson DJ; Kibel AS; Dansonka-Mieszkowska A; Michael A; Dieffenbach AK; Gentry-Maharaj A; Whittemore AS; Wolk A; Monteiro A; Peixoto A; Kierzek A; Cox A; Rudolph A; Gonzalez-Neira A; Wu AH; Lindblom A; Swerdlow A; Ziogas A; Ekici AB; Burwinkel B; Karlan BY; Nordestgaard BG; Blomqvist C; Phelan C; McLean C; Pearce CL; Vachon C; Cybulski C; Slavov C; Stegmaier C; Maier C; Ambrosone CB; Hogdall CK; Teerlink CC; Kang D; Tessier DC; Schaid DJ; Stram DO; Cramer DW; Neal DE; Eccles D; Flesch-Janys D; Edwards DRV; Wokozorczyk D; Levine DA; Yannoukakos D; Sawyer EJ; Bandera EV; Poole EM; Goode EL; Khusnutdinova E; Hogdall E; Song F; Bruinsma F; Heitz F; Modugno F; Hamdy FC; Wiklund F; Giles GG; Olsson H; Wildiers H; Ulmer H-U; Pandha H; Risch HA; Darabi H; Salvesen HB; Nevanlinna H; Gronberg H; Brenner H; Brauch H; Anton-Culver H; Song H; Lim H-Y; McNeish I; Campbell I; Vergote I; Gronwald J; Lubinski J; Stanford JL; Bentez J; Doherty JA; Permuth JB; Chang-Claude J; Donovan JL; Dennis J; Schildkraut JM; Schleutker J; Hopper JL; Kupryjanczyk J; Park JY; Figueroa J; Clements JA; Knight JA; Peto J; Cunningham JM; Pow-Sang J; Batra J; Czene K; Lu KH; Herkommer K; Khaw K-T; Matsuo K; Muir K; Offitt K; Chen K; Moysich KB; Aittomaki K; Odunsi K; Kiemeney LA; Massuger LFAG; Fitzgerald LM; Cook LS; Cannon-Albright L; Hooning MJ; Pike MC; Bolla MK; Luedeke M; Teixeira MR; Goodman MT; Schmidt MK; Riggan M; Aly M; Rossing MA; Beckmann MW; Moisse M; Sanderson M; Southey MC; Jones M; Lush M; Hildebrandt MAT; Hou M-F; Schoemaker MJ; Garcia-Closas M; Bogdanova N; Rahman N; Le ND; Orr N; Wentzensen N; Pashayan N; Peterlongo P; Guenel P; Brennan P; Paulo P; Webb PM; Broberg P; Fasching PA; Devilee P; Wang Q; Cai Q; Li Q; Kaneva R; Butzow R; Kopperud RK; Schmutzler RK; Stephenson RA; MacInnis RJ; Hoover RN; Winqvist R; Ness R; Milne RL; Travis RC; Benlloch S; Olson SH; McDonnell SK; Tworoger SS; Maia SA; Berndt S; Lee SC; Teo S-H; Thibodeau SN; Bojesen SE; Gapstur SM; Kjaer SK; Pejovic T; Tammela TLJ; Doerk T; Bruening T; Wahlfors T; Key TJ; Edwards TL; Menon U; Hamann U; Mitev V; Kosma V-M; Setiawan VW; Kristensen V; Arndt V; Vogel W; Zheng W; Sieh W; Blot WJ; Kluzniak W; Shu X-O; Gao Y-T; Schumacher F; Freedman ML; Berchuck A; Dunning AM; Simard J; Haiman CA; Spurdle A; Sellers TA; Hunter DJ; Henderson BE; Kraft P; Chanock SJ; Couch FJ; Hall P; Gayther SA; Easton DF; Chenevix-Trench G; Eeles R; Pharoah PDP; Lambrechts D
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(15):5050
The Stockholm-3 (STHLM3) model to improve prostate cancer testing in men 50-69 years compared to current clinical practice.
Gronberg H; Adolfsson J; Aly M; Nordstrom T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
Article: NATURE COMMUNICATIONS. 2016;7:10979
Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation
Gusev A; Shi H; Kichaev G; Pomerantz M; Li F; Long HW; Ingles SA; Kittles RA; Strom SS; Rybicki BA; Nemesure B; Isaacs WB; Zheng W; Pettaway CA; Yeboah ED; Tettey Y; Biritwum RB; Adjei AA; Tay E; Truelove A; Niwa S; Chokkalingam AP; John EM; Murphy AB; Signorello LB; Carpten J; Leske MC; Wu S-Y; Hennis AJM; Neslund-Dudas C; Hsing AW; Chu L; Goodman PJ; Klein EA; Witte JS; Casey G; Kaggwa S; Cook MB; Stram DO; Blot WJ; Eeles RA; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Southey MC; Fitzgerald LM; Gronberg H; Wiklund F; Aly M; Henderson BE; Schleutker J; Wahlfors T; Tammela TLJ; Nordestgaard BG; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw K-T; Stanford JL; Thibodeau SN; McDonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Wokolorczyk D; Kluzniak W; Cannon-Albright L; Teerlink C; Brenner H; Dieffenbach AK; Arndt V; Park JY; Sellers TA; Lin H-Y; Slavov C; Kaneva R; Mitev V; Batra J; Spurdle A; Clements JA; Teixeira MR; Pandha H; Michael A; Paulo P; Maia S; Kierzek A; Conti DV; Albanes D; Berg C; Berndt SI; Campa D; Crawford ED; Diver WR; Gapstur SM; Gaziano JM; Giovannucci E; Hoover R; Hunter DJ; Johansson M; Kraft P; Le Marchand L; Lindstrom S; Navarro C; Overvad K; Riboli E; Siddiq A; Stevens VL; Trichopoulos D; Vineis P; Yeager M; Trynka G; Raychaudhuri S; Schumacher FR; Price AL; Freedman ML; Haiman CA; Pasaniuc B; Cook M; Guy M; Govindasami K; Leongamornlert D; Sawyer EJ; Wilkinson R; Saunders EJ; Tymrakiewicz M; Dadaev T; Morgan A; Fisher C; Hazel S; Livni N; Lophatananon A; Pedersen J; Hopper JL; Adolfson J; Stattin P; Johansson J-E; Cavalli-Bjoerkman C; Karlsson A; Broms M; Auvinen A; Kujala P; Maeaettaenen L; Murtola T; Taari K; Weischer M; Nielsen SF; Klarskov P; Roder A; Iversen P; Wallinder H; Gustafsson S; Cox A; Brown P; George A; Marsden G; Lane A; Davis M; Zheng W; Signorello LB; Blot WJ; Tillmans L; Riska S; Wang L; Rinckleb A; Lubiski J; Stegmaier C; Pow-Sang J; Park H; Radlein S; Rincon M; Haley J; Zachariah B; Kachakova D; Popov E; Mitkova A; Vlahova A; Dikov T; Christova S; Heathcote P; Wood G; Malone G; Saunders P; Eckert A; Yeadon T; Kerr K; Collins A; Turner M; Srinivasan S; Kedda M-A; Alexander K; Omara T; Wu H; Henrique R; Pinto P; Santos J; Barros-Silva J
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2016;50(2):104-109
A population-based study on the association between educational length, prostate-specific antigen testing and use of prostate biopsies
Nordstrom T; Bratt O; Ortegren J; Aly M; Adolfsson J; Gronberg H
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2016;15(3):e86
86 The STHLM3 model improves prostate cancer testing in men 50-69 years - further health economic and clinic evaluation
Grönberg H; Adolfsson J; Aly M; Nordström T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
Article: LANCET ONCOLOGY. 2015;16(16):1667-1676
Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study
Gronberg H; Adolfsson J; Aly M; Nordstrom T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2015;24(11):1796-1800
Genome-Wide Association Study of Prostate Cancer-Specific Survival
Szulkin R; Karlsson R; Whitington T; Aly M; Gronberg H; Eeles RA; Easton DF; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Southey MC; FitzGerald LM; Henderson BE; Schumacher FR; Haiman CA; Sipeky C; Tammela TLJ; Nordestgaard BG; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah PDP; Pashayan N; Khaw K-T; Stanford JL; Thibodeau SN; McDonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Lubinski J; Kluzniak W; Cannon-Albright L; Brenner H; Herrmann V; Holleczek B; Park JY; Sellers TA; Lim H-Y; Slavov C; Kaneva RP; Mitev VI; Spurdle A; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; Batra J; Clements JA; Albanes D; Andriole GL; Berndt SI; Chanock S; Gapstur SM; Giovannucci EL; Hunter DJ; Kraft P; Le Marchand L; Ma J; Mondul AM; Penney KL; Stampfer MJ; Stevens VL; Weinstein SJ; Trichopoulou A; Bueno-de-Mesquita BH; Tjonneland A; Cox DG; Maehle L; Schleutker J; Lindstroem S; Wiklund F
Article: HUMAN MOLECULAR GENETICS. 2015;24(19):5589-5602
Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans
Al Olama AA; Dadaev T; Hazelett DJ; Li Q; Leongamornlert D; Saunders EJ; Stephens S; Cieza-Borrella C; Whitmore I; Garcia SB; Giles GG; Southey MC; Fitzgerald L; Gronberg H; Wiklund F; Aly M; Henderson BE; Schumacher F; Haiman CA; Schleutker J; Wahlfors T; Tammela TL; Nordestgaard BG; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw K-T; Stanford JL; Thibodeau SN; Mcdonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Wokolorczyk D; Kluzniak W; Cannon-Albright L; Brenner H; Butterbach K; Arndt V; Park JY; Sellers T; Lin H-Y; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; Spurdle A; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; Govindasami K; Guy M; Lophatonanon A; Muir K; Vinuela A; Brown AA; Freedman M; Conti DV; Easton D; Coetzee GA; Eeles RA; Kote-Jarai Z
Article: PROSTATE. 2015;75(13):1467-1474
Prediction of Individual Genetic Risk to Prostate Cancer Using a Polygenic Score
Szulkin R; Whitington T; Eklund M; Aly M; Eeles RA; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Southey MC; Fitzgerald LM; Henderson BE; Schumacher F; Haiman CA; Schleutker J; Wahlfors T; Tammela TLJ; Nordestgaard BG; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw K-T; Stanford JL; Thibodeau SN; McDonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Lubinski J; Kluzniak W; Cannon-Albright L; Brenner H; Butterbach K; Stegmaier C; Park JY; Sellers T; Lim H-Y; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; Spurdle A; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; Gronberg H; Wiklund F
Article: PROSTATE. 2015;75(9):947-956
Rapid Increase in Multidrug-Resistant Enteric Bacilli Blood Stream Infection After Prostate Biopsy-A 10-Year Population-Based Cohort Study
Aly M; Dyrdak R; Nordstrom T; Jalal S; Weibull CE; Giske CG; Gronberg H
Article: NATURE GENETICS. 2014;46(10):1103-1109
A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer
Al Olama AA; Kote-Jarai Z; Berndt SI; Conti DV; Schumacher F; Han Y; Benlloch S; Hazelett DJ; Wang Z; Saunders E; Leongamornlert D; Lindstrom S; Jugurnauth-Little S; Dadaev T; Tymrakiewicz M; Stram DO; Rand K; Wan P; Stram A; Sheng X; Pooler LC; Park K; Xia L; Tyrer J; Kolonel LN; Le Marchand L; Hoover RN; Machiela MJ; Yeager M; Burdette L; Chung CC; Hutchinson A; Yu K; Goh C; Ahmed M; Govindasami K; Guy M; Tammela TLJ; Auvinen A; Wahlfors T; Schleutker J; Visakorpi T; Leinonen KA; Xu J; Aly M; Donovan J; Travis RC; Key TJ; Siddiq A; Canzian F; Khaw K-T; Takahashi A; Kubo M; Pharoah P; Pashayan N; Weischer M; Nordestgaard BG; Nielsen SF; Klarskov P; Roder MA; Iversen P; Thibodeau SN; McDonnell SK; Schaid DJ; Stanford JL; Kolb S; Holt S; Knudsen B; Coll AH; Gapstur SM; Diver WR; Stevens VL; Maier C; Luedeke M; Herkommer K; Rinckleb AE; Strom SS; Pettaway C; Yeboah ED; Tettey Y; Biritwum RB; Adjei AA; Tay E; Truelove A; Niwa S; Choklcalingam AP; Cannon-Albright L; Cybulski C; Wokolorczyk D; Kluzniak W; Park J; Sellers T; Lin H-Y; Isaacs WB; Partin AW; Brenner H; Dieffenbach AK; Stegmaier C; Chen C; Giovannucci EL; Ma J; Stampfer M; Penney KL; Mucci L; John EM; Ingles SA; Kittles RA; Murphy AB; Pandha H; Michael A; Kierzek AM; Blot W; Signorello LB; Zheng W; Albanes D; Virtamo J; Weinstein S; Nemesure B; Carpten J; Leske C; Wu S-Y; Hennis A; Kibel AS; Rybicki BA; Neslund-Dudas C; Hsing AW; Chu L; Goodman PJ; Klein EA; Zheng SL; Batra J; Clements J; Spurdle A; Teixeira MR; Paulo P; Maia S; Slavov C; Kaneva R; Mitev V; Witte JS; Casey G; Gillanders EM; Seminara D; Riboli E; Hamdy FC; Coetzee GA; Li Q; Freedman ML; Hunter DJ; Muir K; Gronberg H; Nea DE; Southey M; Giles GG; Severi G; Cook MB; Nakagawa H; Wiklund F; Kraft P; Chanock SJ; Henderson BE; Easton DF; Eeles RA; Haiman CA
Article: EUROPEAN UROLOGY. 2014;65(6):1184-1190
A Genetic Score Can Identify Men at High Risk for Prostate Cancer Among Men With Prostate-Specific Antigen of 1-3 ng/ml
Nordstrom T; Aly M; Eklund M; Egevad L; Gronberg H
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2014;13(1):e860
860 STHLM3 – a prospective diagnostic study of prostate cancer
Gronberg H; Eklund M; Clements M; Nordström T; Aly M; Egevad L; Wiklund F; Brandeberg Y; Wiklund P; Adolfsson J
Article: PLOS GENETICS. 2014;10(2):e1004129
Fine-Mapping the HOXB Region Detects Common Variants Tagging a Rare Coding Allele: Evidence for Synthetic Association in Prostate Cancer
Saunders EJ; Dadaev T; Leongamornlert DA; Jugurnauth-Little S; Tymrakiewicz M; Wiklund F; Al Olama AA; Benlloch S; Neal DE; Hamdy FC; Donovan JL; Giles GG; Severi G; Gronberg H; Aly M; Haiman CA; Schumacher F; Henderson BE; Lindstrom S; Kraft P; Hunter DJ; Gapstur S; Chanock S; Berndt SI; Albanes D; Andriole G; Schleutker J; Weischer M; Nordestgaard BG; Canzian F; Campa D; Riboli E; Key TJ; Travis RC; Ingles SA; John EM; Hayes RB; Pharoah P; Khaw K-T; Stanford JL; Ostrander EA; Signorello LB; Thibodeau SN; Schaid D; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park JY; Kaneva R; Batra J; Clements JA; Teixeira MR; Xu J; Mikropoulos C; Goh C; Govindasami K; Guy M; Wilkinson RA; Sawyer EJ; Morgan A; Easton DF; Muir K; Eeles RA; Kote-Jarai Z
Article: EUROPEAN UROLOGY. 2014;65(1):169-176
A Population-based Assessment of Germline HOXB13 G84E Mutation and Prostate Cancer Risk
Karlsson R; Aly M; Clements M; Zheng L; Adolfsson J; Xu J; Gronberg H; Wiklund F
Article: NATURE GENETICS. 2013;45(4):385-391e2
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
Eeles RA; Al Olama AA; Benlloch S; Saunders EJ; Leongamornlert DA; Tymrakiewicz M; Ghoussaini M; Luccarini C; Dennis J; Jugurnauth-Little S; Dadaev T; Neal DE; Hamdy FC; Donovan JL; Muir K; Giles GG; Severi G; Wiklund F; Gronberg H; Haiman CA; Schumacher F; Henderson BE; Le Marchand L; Lindstrom S; Kraft P; Hunter DJ; Gapstur S; Chanock SJ; Berndt SI; Albanes D; Andriole G; Schleutker J; Weischer M; Canzian F; Riboli E; Key TJ; Travis RC; Campa D; Ingles SA; John EM; Hayes RB; Pharoah PDP; Pashayan N; Khaw K-T; Stanford JL; Ostrander EA; Signorello LB; Thibodeau SN; Schaid D; Maier C; Vogel W; Kibel AS; Cybulski C; Lubhiski J; Cannon-Albright L; Brenner H; Park JY; Kaneva R; Batra J; Spurdle AB; Clements JA; Teixeira MR; Dicks E; Lee A; Dunning AM; Baynes C; Conroy D; Maranian MJ; Ahmed S; Govindasami K; Guy M; Wilkinson RA; Sawyer EJ; Morgan A; Dearnaley DP; Horwich A; Huddart RA; Khoo VS; Parker CC; Van As NJ; Woodhouse CJ; Thompson A; Dudderidge T; Ogden C; Cooper CS; Lophatananon A; Cox A; Southey MC; Hopper JL; English DR; Aly M; Adolfsson J; Xu J; Zheng SL; Yeager M; Kaaks R; Diver WR; Gaudet MM; Stern MC; Corral R; Joshi AD; Shahabi A; Wahlfors T; Tammela TLJ; Auvinen A; Virtamo J; Klarskov P; Nordestgaard BG; Roder MA; Nielsen SF; Bojesen SE; Siddiq A; FitzGerald LM; Kolb S; Kwon EM; Karyadi DM; Blot WJ; Zheng W; Cai Q; McDonnell SK; Rinckleb AE; Drake B; Colditz G; Wokolorczyk D; Stephenson RA; Teerlink C; Muller H; Rothenbacher D; Sellers TA; Lin H-Y; Slavov C; Mitev V; Lose F; Srinivasan S; Maia S; Paulo P; Lange E; Cooney KA; Antoniou AC; Vincent D; Bacot F; Tessier DC; Kote-Jarai Z; Easton DF
Article: EUROPEAN UROLOGY. 2013;63(3):419-425
Prostate-specific Antigen (PSA) Testing Is Prevalent and Increasing in Stockholm County, Sweden, Despite No Recommendations for PSA Screening: Results from a Population-based Study, 2003-2011
Nordstrom T; Aly M; Clements MS; Weibull CE; Adolfsson J; Gronberg H
Article: HUMAN MOLECULAR GENETICS. 2013;22(2):408-415
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease
Al Olama AA; Kote-Jarai Z; Schumacher FR; Wiklund F; Berndt SI; Benlloch S; Giles GG; Severi G; Neal DE; Hamdy FC; Donovan JL; Hunter DJ; Henderson BE; Thun MJ; Gaziano M; Giovannucci EL; Siddiq A; Travis RC; Cox DG; Canzian F; Riboli E; Key TJ; Andriole G; Albanes D; Hayes RB; Schleutker J; Auvinen A; Tammela TLJ; Weischer M; Stanford JL; Ostrander EA; Cybulski C; Lubinski J; Thibodeau SN; Schaid DJ; Sorensen KD; Batra J; Clements JA; Chambers S; Aitken J; Gardiner RA; Maier C; Vogel W; Doerk T; Brenner H; Habuchi T; Ingles S; John EM; Dickinson JL; Cannon-Albright L; Teixeira MR; Kaneva R; Zhang H-W; Lu Y-J; Park JY; Cooney KA; Muir KR; Leongamornlert DA; Saunders E; Tymrakiewicz M; Mahmud N; Guy M; Govindasami K; O'Brien LT; Wilkinson RA; Hall AL; Sawyer EJ; Dadaev T; Morrison J; Dearnaley DP; Horwich A; Huddart RA; Khoo VS; Parker CC; Van As N; Woodhouse CJ; Thompson A; Dudderidge T; Ogden C; Cooper CS; Lophatonanon A; Southey MC; Hopper JL; English D; Virtamo J; Le Marchand L; Campa D; Kaaks R; Lindstrom S; Diver WR; Gapstur S; Yeager M; Cox A; Stern MC; Corral R; Aly M; Isaacs W; Adolfsson J; Xu J; Zheng SL; Wahlfors T; Taari K; Kujala P; Klarskov P; Nordestgaard BG; Roder MA; Frikke-Schmidt R; Bojesen SE; FitzGerald LM; Kolb S; Kwon EM; Karyadi DM; Orntoft TF; Borre M; Rinckleb A; Luedeke M; Herkommer K; Meyer A; Serth J; Marthick JR; Patterson B; Wokolorczyk D; Spurdle A; Lose F; McDonnell SK; Joshi AD; Shahabi A; Pinto P; Santos J; Ray A; Sellers TA; Lin H-Y; Stephenson RA; Teerlink C; Muller H; Rothenbacher D; Tsuchiya N; Narita S; Cao G-W; Slavov C; Mitev V; Chanock S; Gronberg H; Haiman CA; Kraft P; Easton DF; Eeles RA
Article: NATURE GENETICS. 2011;43(8):785-U96
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
Kote-Jarai Z; Al Olama AA; Giles GG; Severi G; Schleutker J; Weischer M; Campa D; Riboli E; Key T; Gronberg H; Hunter DJ; Kraft P; Thun MJ; Ingles S; Chanock S; Albanes D; Hayes RB; Neal DE; Hamdy FC; Donovan JL; Pharoah P; Schumacher F; Henderson BE; Stanford JL; Ostrander EA; Sorensen KD; Dork T; Andriole G; Dickinson JL; Cybulski C; Lubinski J; Spurdle A; Clements JA; Chambers S; Aitken J; Gardiner RAF; Thibodeau SN; Schaid D; John EM; Maier C; Vogel W; Cooney KA; Park JY; Cannon-Albright L; Brenner H; Habuchi T; Zhang H-W; Lu Y-J; Kaneva R; Muir K; Benlloch S; Leongamornlert DA; Saunders EJ; Tymrakiewicz M; Mahmud N; Guy M; O'Brien LT; Wilkinson RA; Hall AL; Sawyer EJ; Dadaev T; Morrison J; Dearnaley DP; Horwich A; Huddart RA; Khoo VS; Parker CC; Van As N; Woodhouse CJ; Thompson A; Christmas T; Ogden C; Cooper CS; Lophatonanon A; Southey MC; Hopper JL; English DR; Wahlfors T; Tammela TLJ; Klarskov P; Nordestgaard BG; Roder MA; Tybjaerg-Hansen A; Bojesen SE; Travis R; Canzian F; Kaaks R; Wiklund F; Aly M; Lindstrom S; Diver WR; Gapstur S; Stern MC; Corral R; Virtamo J; Cox A; Haiman CA; Le Marchand L; FitzGerald L; Kolb S; Kwon EM; Karyadi DM; Orntoft TF; Borre M; Meyer A; Serth J; Yeager M; Berndt SI; Marthick JR; Patterson B; Wokolorczyk D; Batra J; Lose F; McDonnell SK; Joshi AD; Shahabi A; Rinckleb AE; Ray A; Sellers TA; Lin H-Y; Stephenson RA; Farnham J; Muller H; Rothenbacher D; Tsuchiya N; Narita S; Cao G-W; Slavov C; Mitev V; Easton DF; Eeles RA
Article: EUROPEAN UROLOGY. 2011;60(1):21-28
Polygenic Risk Score Improves Prostate Cancer Risk Prediction: Results from the Stockholm-1 Cohort Study
Aly M; Wiklund F; Xu J; Isaacs WB; Eklund M; D'Amato M; Adolfsson J; Gronberg H
Article: BMC MEDICAL GENOMICS. 2010;3:59
Birt-Hogg-Dube renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression
Klomp JA; Petillo D; Niemi NM; Dykema KJ; Chen J; Yang XJ; Saaf A; Zickert P; Aly M; Bergerheim U; Nordenskjold M; Gad S; Giraud S; Denoux Y; Yonneau L; Mejean A; Vasiliu V; Richard S; MacKeigan JP; Teh BT; Furge KA
Show more

All other publications

Letter: PATHOLOGY. 2024;56(7):1059-1061
Benign prostatic hyperplasia and insignificant prostate cancer with very high levels of serum prostate specific antigen
Samaratunga H; Delahunt B; Olsson M; Aly M; Egevad L; Yaxley J
Letter: SCANDINAVIAN JOURNAL OF UROLOGY. 2024;59:137-140
A population-based registry cohort study on the correlation between bladder- intact event-free survival and overall survival in cystectomy-ineligible/refusal muscle-invasive bladder cancer patients in Sweden
Laurin O; Baculea S; Cote S; Spigelman S; Szulkin R; Kwok KHM; Schain F; Jones CV; Aly M
Conference publication: JOURNAL OF UROLOGY. 2023;209:E997-E998
THE STOCKHOLM3 PROSTATE CANCER SCREENING TRIAL (STHLM3): AN INTERIM ANALYSIS OF MORTALITY RESULTS AFTER 6.5 YEARS OF FOLLOW-UP
Micoli C; Crippa A; Discacciati A; Palsdottir T; Vigneswaran H; Aly M; Adolfsson J; Lindberg J; Wiklund P; Thompson J; Brandberg Y; Clements M; Egevad L; Gronberg H; Nordstrom T; Eklund M
Conference publication: EUROPEAN UROLOGY. 2023;83:S208
The risk of arterial thromboembolic complications in bladder cancer patients after radical cystectomy - population-based nationwide matched cohort study
Rautiola J; Bjorklund J; Zelic R; Vincent PH; Wiklund P; Aly M; Akre O
Conference publication: EUROPEAN UROLOGY. 2023;83:S371
The risk of ischemic stroke and myocardial infarction in prostate cancer patients treated with radical prostatectomy - population-based nationwide matched cohort study
Rautiola J; Bjorklund J; Zelic R; Vincent PH; Wiklund P; Aly M; Akre O
Conference publication: JOURNAL OF UROLOGY. 2023;209:E214-E215
VALIDATION OF EAU RISK GROUPS FOR BIOCHEMICAL RECURRENCE AFTER RADIOTHERAPY AND RADICAL PROSTATECTOMY FOR PREDICTION OF PROSTATE CANCER MORTALITY
Falagario U; Bogdanovic D; Bjornebo L; Abbadi A; Valdman A; Eklund M; Nordstrom T; Aly M; Gronberg H; Lantz A; Wiklund P
Conference publication: JOURNAL OF UROLOGY. 2023;209:E419
PREDICTION OF PROSTATE CANCER SPECIFIC MORTALITY IN MEN UNDERGOING RADIOTHERAPY WITH OR WITHOUT HORMONAL TREATMENT, RISK STRATIFICATION BASED ON CLINICAL CHARACTERISTICS AND PSA TREATMENT RESPONSE
Falagario U; Bogdanovic D; Bjornebo L; Abbadi A; Valdman A; Eklund M; Nordstrom T; Aly M; Gronberg H; Wiklund P; Lantz A
Conference publication: EUROPEAN UROLOGY. 2023;83:S209-S210
The risk of Venous thromboembolic events in patients operated with radical cystectomy - a nationwide population-based cohort study
Bjorklund J; Rautiola J; Zelic R; Vincent PH; Wiklund P; Aly M; Akre O
Conference publication: EUROPEAN UROLOGY. 2023;83:S379-S380
Validation of EAU Risk groups for biochemical recurrence after radiotherapy and radical prostatectomy for prediction of prostate cancer mortality
Falagario UG; Bogdanovic D; Bjornebo L; Abbadi A; Valdman A; Eklund M; Nordstrom T; Aly M; Gronberg H; Lantz A; Wiklund P
Conference publication: EUROPEAN UROLOGY. 2023;83:S369-S370
The risk of venous thromboembolic events among men operated with radical prostatectomy - A nationwide population-based cohort study
Bjorklund J; Rautiola J; Zelic R; Vincent PH; Wiklund P; Aly M; Akre O
Conference publication: EUROPEAN UROLOGY. 2022;81:S792-S793
Disease trajectories and outcomes for men with castration resistant prostate cancer by use of nation-wide population-based observational data
Ventimiglia E; Bill-Axelson A; Aly M; Eklund M; Stattin P; Garmo H
Conference publication: JOURNAL OF UROLOGY. 2022;207(5):E41
LONG-TERM EFFECTS OF 5A-REDUCTASE INHIBITORS ON PROSTATE CANCER MORTALITY - A LARGE POPULATION-BASED PROSPECTIVE STUDY
Bjornebo L; Nordstrom T; Discacciati A; Palsdottir T; Aly M; Gronberg H; Eklund M; Lantz A
Conference publication: EUROPEAN UROLOGY. 2022;81:S561-S562
Long-term effects of 5α-reductase inhibitors on prostate cancer mortality: A large population-based prospective study
Bjornebo L; Nordstrom T; Discacciati A; Palsdottir T; Aly M; Gronberg H; Eklund M; Lantz A
Editorial comment: JOURNAL OF UROLOGY. 2022;207(1):231
Re: MRI-Targeted or Standard Biopsy in Prostate Cancer Screening
Eklund M; Jaderling F; Discacciati A; Bergman M; Annerstedt M; Aly M; Glaessgen A; Carlsson S; Gronberg H; Nordstrom T
Corrigendum: NATURE GENETICS. 2021;53(3):413
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (vol 53, pg 65, 2021)
Conti DV; Darst BF; Moss LC; Saunders EJ; Sheng X; Chou A; Schumacher FR; Al Olama AA; Benlloch S; Dadaev T; Brook MN; Sahimi A; Hoffmann TJ; Takahashi A; Matsuda K; Momozawa Y; Fujita M; Muir K; Lophatananon A; Wan P; Le Marchand L; Wilkens LR; Stevens VL; Gapstur SM; Carter BD; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Giles GG; Southey MC; MacInnis RJ; Cybulski C; Wokolorczyk D; Lubinski J; Neal DE; Donovan JL; Hamdy FC; Martin RM; Nordestgaard BG; Nielsen SF; Weischer M; Bojesen SE; Roder MA; Iversen P; Batra J; Chambers S; Moya L; Horvath L; Clements JA; Tilley W; Risbridger GP; Gronberg H; Aly M; Szulkin R; Eklund M; Nordstrom T; Pashayan N; Dunning AM; Ghoussaini M; Travis RC; Key TJ; Riboli E; Park JY; Sellers TA; Lin H-Y; Albanes D; Weinstein SJ; Mucci LA; Giovannucci E; Lindstrom S; Kraft P; Hunter DJ; Penney KL; Turman C; Tangen CM; Goodman PJ; Thompson IMJ; Hamilton RJ; Fleshner NE; Finelli A; Parent M-E; Stanford JL; Ostrander EA; Geybels MS; Koutros S; Freeman LEB; Stampfer M; Wolk A; Hakansson N; Andriole GL; Hoover RN; Machiela MJ; Sorensen KD; Borre M; Blot WJ; Zheng W; Yeboah ED; Mensah JE; Lu Y-J; Zhang H-W; Feng N; Mao X; Wu Y; Zhao S-C; Sun Z; Thibodeau SN; McDonnell SK; Schaid DJ; West CML; Burnet N; Barnett G; Maier C; Schnoeller T; Luedeke M; Kibel AS; Drake BF; Cussenot O; Cancel-Tassin G; Menegaux F; Truong T; Koudou YA; John EM; Grindedal EM; Maehle L; Khaw K-T; Ingles SA; Stern MC; Vega A; Gomez-Caamano A; Fachal L; Rosenstein BS; Kerns SL; Ostrer H; Teixeira MR; Paulo P; Brandao A; Watya S; Lubwama A; Bensen JT; Fontham ETH; Mohler J; Taylor JA; Kogevinas M; Llorca J; Castano-Vinyals G; Cannon-Albright L; Teerlink CC; Huff CD; Strom SS; Multigner L; Blanchet P; Brureau L; Kaneva R; Slavov C; Mitev V; Leach RJ; Weaver B; Brenner H; Cuk K; Holleczek B; Saum K-U; Klein EA; Hsing AW; Kittles RA; Murphy AB; Logothetis CJ; Kim J; Neuhausen SL; Steele L; Ding YC; Isaacs WB; Nemesure B; Hennis AJM; Carpten J; Pandha H; Michael A; De Ruyck K; De Meerleer G; Ost P; Xu J; Razack A; Lim J; Teo S-H; Newcomb LF; Lin DW; Fowke JH; Neslund-Dudas C; Rybicki BA; Gamulin M; Lessel D; Kulis T; Usmani N; Singhal S; Parliament M; Claessens F; Joniau S; Van den Broeck T; Gago-Dominguez M; Castelao JE; Martinez ME; Larkin S; Townsend PA; Aukim-Hastie C; Bush WS; Aldrich MC; Crawford DC; Srivastava S; Cullen JC; Petrovics G; Casey G; Roobol MJ; Jenster G; van Schaik RHN; Hu JJ; Sanderson M; Varma R; McKean-Cowdin R; Torres M; Mancuso N; Berndt SI; Van den Eeden SK; Easton DF; Chanock SJ; Cook MB; Wiklund F; Nakagawa H; Witte JS; Eeles RA; Kote-Jarai Z; Haiman CAAll authors
Conference publication: EUROPEAN UROLOGY. 2021;79:S1429
Prostate cancer screening using prostate-specific antigen, a multiplex blood-test, magnetic resonance imaging and targeted prostate biopsies: The STHLM3MRI trial
Nordstrom T; Discacciati A; Bergman M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jaderling F; Eklund M; Gronberg H
Conference publication: EUROPEAN UROLOGY. 2021;79:S1430
MRI-targeted or systematic biopsies in prostate cancer screening: The STHLM3MRI trial
Eklund M; Jaderling F; Discacciati A; Bergman M; Annerstedt M; Aly M; Glaessgen A; Carlsson S; Gronberg H; Nordstrom T
Preprint: SSRN ELECTRONIC JOURNAL. 2021
Prostate Cancer Screening Using a Combination of Risk-Prediction, Magnetic Resonance Imaging and Targeted Prostate Biopsies: A Randomised Trial
Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H
Conference publication: JOURNAL OF UROLOGY. 2020;203:E247-E248
REAL-WORLD TREATMENT PATTERNS IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER
Vigneswaran HT; Warnqvist A; Andersson TML; Leval A; Schain F; Liwing J; Eloranta S; Pettersson A; Akre O; Aly M
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(6)
MRI-targeted biopsies in prostate cancer screening and the value of its combination with blood-based risk-prediction: The randomized, diagnostic study STHLM3MRI
Nordstrom T; Discacciati A; Jaderling F; Karlsson SG; Aly M; Gronberg H; Eklund M
Review: EUROPEAN UROLOGY FOCUS. 2019;5(5):788-798
Time-to-event Outcomes in Men with Nonmetastatic Castrate-resistant Prostate Cancer-A Systematic Literature Review and Pooling of Individual Participant Data
Aly M; Hashim M; Heeg B; Liwing J; Leval A; Mehra M; Lawson J; Brookman-May SD; Akre O
Preprint: BIORXIV. 2019
The effect of sample size on polygenic hazard models for prostate cancer
Karunamuni RA; Huynh-Le M-P; Fan CC; Eeles RA; Easton DF; Kote-Jarai Z; Al Olama AA; Garcia SB; Muir K; Gronberg H; Wiklund F; Aly M; Schleutker J; Sipeky C; Tammela TL; Nordestgaard BG; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw K-T; Thibodeau SN; McDonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Wokolorczyk D; Kluzniak W; Cannon-Albright L; Brenner H; Schöttker B; Holleczek B; Park JY; Sellers TA; Lin H-Y; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; Spurdle A; BioResource APC; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Mills IG; Andreassen OA; Dale AM; Seibert TM; Consortium TP
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(15):e16555
Survival in men diagnosed with castration resistant prostate cancer: A population-based observational study in Sweden.
Aly M; Schain F; Leval A; Liwing J; Lawson J; Vago E; Nordstrom T; Gronberg H; Andersson TM-L; Sjoland E; Wang C; Eloranta S; Akre O
Preprint: BIORXIV. 2019
A genetic hazard score to personalize prostate cancer screening, applied to population data
Huynh-Le M-P; Fan CC; Karunamuni R; Walsh EI; Turner EL; Lane JA; Martin RM; Neal DE; Donovan JL; Hamdy FC; Parsons JK; Eeles RA; Easton DF; Kote-Jarai Z; Al Olama AA; Garcia SB; Muir K; Gronberg H; Wiklund F; Aly M; Schleutker J; Sipeky C; Tammela TL; Nordestgaard BG; Key TJ; Travis RC; Pharoah P; Pashayan N; Khaw K-T; Thibodeau SN; McDonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Wokolorczyk D; Kluzniak W; Cannon-Albright L; Brenner H; Schöttker B; Holleczek B; Park JY; Sellers TA; Lin H-Y; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; Spurdle A; BioResource APC; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; Mills IG; Andreassen OA; Dale AM; Seibert TM; Consortium TP
Conference publication: RADIOTHERAPY AND ONCOLOGY. 2019;133:S824-S825
Postoperative radiation therapy following radical prostatectomy in Stockholm County in 2008-2016
Falk J; Aly M; Nordstrom T; Valdman A
Corrigendum: NATURE GENETICS. 2019;51(2):363
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (vol 50, pg 928, 2018)
Schumacher FR; Al Olama AA; Berndt SI; Benlloch S; Ahmed M; Saunders EJ; Dadaev T; Leongamornlert D; Anokian E; Cieza-Borrella C; Goh C; Brook MN; Sheng X; Fachal L; Dennis J; Tyrer J; Muir K; Lophatananon A; Stevens VL; Gapstur SM; Carter BD; Tangen CM; Goodman PJ; Thompson IMJ; Batra J; Chambers S; Moya L; Clements J; Horvath L; Tilley W; Risbridger GP; Gronberg H; Aly M; Nordstrom T; Pharoah P; Pashayan N; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Albanes D; Weinstein S; Wolk A; Hakansson N; West CML; Dunning AM; Burnet N; Mucci LA; Giovannucci E; Andriole GL; Cussenot O; Cancel-Tassin G; Koutros S; Freeman LEB; Sorensen KD; Orntoft TF; Borre M; Maehle L; Grindedal EM; Neal DE; Donovan JL; Hamdy FC; Martin RM; Travis RC; Key TJ; Hamilton RJ; Fleshner NE; Finelli A; Ingles SA; Stern MC; Rosenstein BS; Kerns SL; Ostrer H; Lu Y-J; Zhang H-W; Feng N; Mao X; Guo X; Wang G; Sun Z; Giles GG; Southey MC; MacInnis RJ; FitzGerald LM; Kibel AS; Drake BF; Vega A; Gomez-Caamano A; Szulkin R; Eklund M; Kogevinas M; Llorca J; Castano-Vinyals G; Penney KL; Stampfer M; Park JY; Sellers TA; Lin H-Y; Stanford JL; Cybulski C; Wokolorczyk D; Lubinski J; Ostrander EA; Geybels MS; Nordestgaard BG; Nielsen SF; Weischer M; Bisbjerg R; Roder MA; Iversen P; Brenner H; Cuk K; Holleczek B; Maier C; Luedeke M; Schnoeller T; Kim J; Logothetis CJ; John EM; Teixeira MR; Paulo P; Cardoso M; Neuhausen SL; Steele L; Ding YC; De Ruyck K; De Meerleer G; Ost P; Razack A; Lim J; Teo S-H; Lin DW; Newcomb LF; Lessel D; Gamulin M; Kulis T; Kaneva R; Usmani N; Singhal S; Slavov C; Mitev V; Parliament M; Claessens F; Joniau S; Van den Broeck T; Larkin S; Townsend PA; Aukim-Hastie C; Gago-Dominguez M; Castelao JE; Martinez ME; Roobol MJ; Jenster G; van Schaik RHN; Menegaux F; Truong T; Koudou YA; Xu J; Khaw K-T; Cannon-Albright L; Pandha H; Michael A; Thibodeau SN; McDonnell SK; Schaid DJ; Lindstrom S; Turman C; Ma J; Hunter DJ; Riboli E; Siddiq A; Canzian F; Kolonel LN; Le Marchand L; Hoover RN; Machiela MJ; Cui Z; Kraft P; Amos CI; Conti DV; Easton DF; Wiklund F; Chanock SJ; Henderson BE; Kote-Jarai Z; Haiman CA; Eeles RA
Corrigendum: NATURE COMMUNICATIONS. 2019;10(1):382
Germline variation at 8q24 and prostate cancer risk in men of European ancestry (vol 9, 4616, 2018)
Matejcic M; Saunders EJ; Dadaev T; Brook MN; Wang K; Sheng X; Al Olama AA; Schumacher FR; Ingles SA; Govindasami K; Benlloch S; Berndt SI; Albanes D; Koutros S; Muir K; Stevens VL; Gapstur SM; Tangen CM; Batra J; Clements J; Gronberg H; Pashayan N; Schleutker J; Wolk A; West C; Mucci L; Kraft P; Cancel-Tassin G; Sorensen KD; Maehle L; Grindedal EM; Strom SS; Neal DE; Hamdy FC; Donovan JL; Travis RC; Hamilton RJ; Rosenstein B; Lu Y-J; Giles GG; Kibel AS; Vega A; Bensen JT; Kogevinas M; Penney KL; Park JY; Stanford JL; Cybulski C; Nordestgaard BG; Brenner H; Maier C; Kim J; Teixeira MR; Neuhausen SL; De Ruyck K; Razack A; Newcomb LF; Lessel D; Kaneva R; Usmani N; Claessens F; Townsend PA; Gago-Dominguez M; Roobol MJ; Menegaux F; Khaw K-T; Cannon-Albright LA; Pandha H; Thibodeau SN; Schaid DJ; Wiklund F; Chanock SJ; Easton DF; Eeles RA; Kote-Jarai Z; Conti DV; Haiman CA; Henderson BE; Stern MC; Thwaites A; Guy M; Whitmore I; Morgan A; Fisher C; Hazel S; Livni N; Cook M; Fachal L; Weinstein S; Freeman LEB; Hoover RN; Machiela MJ; Lophatananon A; Carter BD; Goodman P; Moya L; Srinivasan S; Kedda M-A; Yeadon T; Eckert A; Eklund M; Cavalli-Bjoerkman C; Dunning AM; Sipeky C; Hakansson N; Elliott R; Ranu H; Giovannucci E; Turman C; Hunter DJ; Cussenot O; Orntoft TF; Lane A; Lewis SJ; Davis M; Key TJ; Brown P; Kulkarni GS; Zlotta AR; Fleshner NE; Finelli A; Mao X; Marzec J; MacInnis RJ; Milne R; Hopper JL; Aguado M; Bustamante M; Castano-Vinyals G; Gracia-Lavedan E; Cecchini L; Stampfer M; Ma J; Sellers TA; Geybels MS; Park H; Zachariah B; Kolb S; Wokolorczyk D; Lubinski J; Kluzniak W; Nielsen SF; Weisher M; Cuk K; Vogel W; Luedeke M; Logothetis CJ; Paulo P; Cardoso M; Maia S; Silva MP; Steele L; Ding YC; De Meerleer G; De Langhe S; Thierens H; Lim J; Tan MH; Ong AT; Lin DW; Kachakova D; Mitkova A; Mitev V; Parliament M; Jenster G; Bangma C; Schroder FH; Truong T; Koudou YA; Michael A; Kierzek A; Karlsson A; Broms M; Wu H; Aukim-Hastie C; Tillmans L; Riska S; McDonnell SK; Dearnaley D; Spurdle A; Gardiner R; Hayes V; Butler L; Taylor R; Papargiris M; Saunders P; Kujala P; Talala K; Taari K; Bentzen S; Hicks B; Vogt A; Hutchinson A; Cox A; George A; Toi A; Evans A; van der Kwast TH; Imai T; Saito S; Zhao S-C; Ren G; Zhang Y; Yu Y; Wu Y; Wu J; Zhou B; Pedersen J; Lobato-Busto R; Manuel Ruiz-Dominguez J; Mengual L; Alcaraz A; Pow-Sang J; Herkommer K; Vlahova A; Dikov T; Christova S; Carracedo A; Tretarre B; Rebillard X; Mulot C; Adolfsson J; Stattin P; Johansson J-E; Martin RM; Thompson IMJ; Chambers S; Aitken J; Horvath L; Haynes A-M; Tilley W; Risbridger G; Aly M; Nordstrom T; Pharoah P; Tammela TLJ; Murtola T; Auvinen A; Burnet N; Barnett G; Andriole G; Klim A; Drake BF; Borre M; Kerns S; Ostrer H; Zhang H-W; Cao G; Lin J; Ling J; Li M; Feng N; Li J; He W; Guo X; Sun Z; Wang G; Guo J; Southey MC; FitzGerald LM; Marsden G; Gomez-Caamano A; Carballo A; Peleteiro P; Calvo P; Szulkin R; Llorca J; Dierssen-Sotos T; Gomez-Acebo I; Lin H-Y; Ostrander EA; Bisbjerg R; Klarskov P; Roder MA; Iversen P; Holleczek B; Stegmaier C; Schnoeller T; Bohnert P; John EM; Ost P; Teo S-H; Gamulin M; Kulis T; Kastelan Z; Slavov C; Popov E; Van den Broeck T; Joniau S; Larkin S; Esteban Castelao J; Martinez ME; van Schaik RHN; Xu J; Lindstrom S; Riboli E; Berry C; Siddiq A; Canzian F; Kolonel LN; Le Marchand L; Freedman M; Cenee S; Sanchez M
Editorial comment: EUROPEAN UROLOGY FOCUS. 2017;3(6):526-528
Detection of Prostate Cancer Using a Multistep Approach with Prostate-specific Antigen, the Stockholm 3 Test, and Targeted Biopsies: The STHLM3 MRI Project
Nordstrom T; Picker W; Aly M; Jaderling F; Adolfsson J; Strom P; Haug ES; Eklund M; Carlsson S; Gronberg H
Other: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2017;35(3):120
Prostate cancer screening in men aged 50 to 69 years (STHLM3): A prospective population-based diagnostic study. Grönberg H, Adolfsson J, Aly M, Nordström T, Wiklund P, Brandberg Y, Thompson J, Wiklund F, Lindberg J, Clements M, Egevad L, Eklund M.Lancet Oncol. 2015 Dec;16(16):1667-76. [Epub 2015 Nov 10]. doi: 10.1016/S1470-2045(15)00361-7.
Scott E; Adolfsson J; Aly M; Nordström T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
Preprint: BIORXIV. 2016
A genetic risk score to guide age-specific, personalized prostate cancer screening
Seibert TM; Fan CC; Wang Y; Zuber V; Karunamuni R; Parsons JK; Eeles RA; Easton DF; Kote-Jarai Z; Al Olama AA; Garcia SB; Muir K; Gronberg H; Wiklund F; Aly M; Schleutker J; Sipeky C; Tammela TL; Nordestgaard BG; Nielsen SF; Weischer M; Bisbjerg R; Røder MA; Iversen P; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw K-T; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Wokolorczyk D; Kluzniak W; Cannon-Albright L; Brenner H; Cuk K; Saum K-U; Park JY; Sellers TA; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; Spurdle A; BioResource APC; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; Karow DS; Mills IG; Andreassen OA; Dale AM; consortium TP
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(2):36
The risk-based STHLM3 model to improve prostate cancer testing in men 50-69 years: Further health, economic, and clinic evaluation
Gronberg H; Adolfsson J; Aly M; Nordstrom T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
Doctoral thesis: 2014
Prostate cancer diagnostics : complications and ways to reduce unnecessary biopsies
Aly M
Review: ACTA ONCOLOGICA. 2011;50:18-23
Early detection of prostate cancer with emphasis on genetic markers
Aly M; Wiklund F; Gronberg H
Show more

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI